AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
One Parkinson's disease early warning sign that often gets overlooked - not tremors
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
The Pharma Letter4d
Growing emphasis on disease-modifying therapies in Parkinson’s
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
Lesser-known symptoms of diabetes, heart disease, dementia and Parkinson’s
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
Benzinga.com1d
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Patients from Part 2 will be evaluated for the progression of motor and non-motor symptoms and digital ... validated ...
WESA4d
Pitt to advance research into improving mobility for Parkinson’s patients
The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.
Neuroscience News12d
RNA Structures Linked to Parkinson’s Protein Aggregates
Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...
News Medical on MSN2d
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Yahoo Finance8d
Parkinson’s disease clinical research in 7MM focuses on disease-modifying agents
While Parkinson’s disease (PD) has a large and highly generalised ... and therapies addressing non-motor symptoms. Currently, ...
Science Daily12d
Scientists discover key to preventing neurodegeneration in Parkinson's and related disorders
A team of researchers has uncovered a groundbreaking mechanism in the formation of harmful protein aggregates that lead to neurodegenerative diseases such as Parkinson's Disease. The team, led by ...